Quality of life in benign colorectal disease-a review of the assessment with the Gastrointestinal Quality of Life Index (GIQLI).
Benign colorectal disease
Constipation
Diverticulitis
Fecal incontinence
GIQLI
Gastrointestinal Quality of Life Index
Quality of life
Journal
International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899
Informations de publication
Date de publication:
20 Jun 2023
20 Jun 2023
Historique:
accepted:
08
06
2023
medline:
22
6
2023
pubmed:
20
6
2023
entrez:
20
6
2023
Statut:
epublish
Résumé
The Gastrointestinal Quality of Life Index (GIQLI) is an instrument for the assessment of quality of life (QOL) in diseases of the upper and lower GI tract, which is validated in several languages around the world. The purpose of this literature review is the assessment of the GIQLI in patients with benign colorectal diseases. Reports on GIQLI data are collected from several institutions, countries, and different cultures which allows for comparisons, which are lacking in literature. The GIQL Index uses 36 items around 5 dimensions (gastrointestinal symptoms (19 items), emotional dimension (5 items), physical dimension (7 items), social dimension (4 items), and therapeutic influences (1 item). The literature search was performed on the GIQLI and colorectal disease, using reports in PubMed. Data are presented descriptively as GIQL Index points as well as a reduction from 100% maximum possible index points (max 144 index points = highest quality of life). The GIQLI was found in 122 reports concerning benign colorectal diseases, of which 27 were finally selected for detailed analysis. From these 27 studies, information on 5664 patients (4046 female versus 1178 male) was recorded and summarized. The median age was 52 years (range 29-74.7). The median GIQLI of all studies concerning benign colorectal disease was 88 index points (range 56.2-113). Benign colorectal disease causes a severe reduction in QOL for patients down to 61% of the maximum. Benign colorectal diseases cause substantial reductions in the patient's QOL, well documented by GIQLI, which allows a comparison QOL with other published cohorts.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
The Gastrointestinal Quality of Life Index (GIQLI) is an instrument for the assessment of quality of life (QOL) in diseases of the upper and lower GI tract, which is validated in several languages around the world. The purpose of this literature review is the assessment of the GIQLI in patients with benign colorectal diseases. Reports on GIQLI data are collected from several institutions, countries, and different cultures which allows for comparisons, which are lacking in literature.
METHODS
METHODS
The GIQL Index uses 36 items around 5 dimensions (gastrointestinal symptoms (19 items), emotional dimension (5 items), physical dimension (7 items), social dimension (4 items), and therapeutic influences (1 item). The literature search was performed on the GIQLI and colorectal disease, using reports in PubMed. Data are presented descriptively as GIQL Index points as well as a reduction from 100% maximum possible index points (max 144 index points = highest quality of life).
RESULTS
RESULTS
The GIQLI was found in 122 reports concerning benign colorectal diseases, of which 27 were finally selected for detailed analysis. From these 27 studies, information on 5664 patients (4046 female versus 1178 male) was recorded and summarized. The median age was 52 years (range 29-74.7). The median GIQLI of all studies concerning benign colorectal disease was 88 index points (range 56.2-113). Benign colorectal disease causes a severe reduction in QOL for patients down to 61% of the maximum.
CONCLUSIONS
CONCLUSIONS
Benign colorectal diseases cause substantial reductions in the patient's QOL, well documented by GIQLI, which allows a comparison QOL with other published cohorts.
Identifiants
pubmed: 37338676
doi: 10.1007/s00384-023-04473-y
pii: 10.1007/s00384-023-04473-y
pmc: PMC10282040
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
172Informations de copyright
© 2023. The Author(s).
Références
Langenbecks Arch Surg. 2020 Feb;405(1):107-116
pubmed: 31956952
Gastroenterol Rep (Oxf). 2019 Jul 16;7(5):361-366
pubmed: 31687156
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Ann Surg. 2008 May;247(5):759-65
pubmed: 18438112
United European Gastroenterol J. 2014 Dec;2(6):544-6
pubmed: 25436111
Br J Surg. 1998 Dec;85(12):1716-9
pubmed: 9876082
Am J Obstet Gynecol. 2023 Apr;228(4):449.e1-449.e13
pubmed: 36509175
Int J Colorectal Dis. 2013 Feb;28(2):227-33
pubmed: 22885883
Chirurg. 1993 Apr;64(4):264-74
pubmed: 8482141
Gastroenterol Clin Biol. 2004 Jan;28(1):11-5
pubmed: 15041804
World J Gastroenterol. 2018 Jun 21;24(23):2491-2500
pubmed: 29930470
Ann Surg. 2009 Feb;249(2):218-24
pubmed: 19212173
Hum Reprod. 2019 Dec 1;34(12):2362-2371
pubmed: 31820806
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Sep 25;25(9):784-791
pubmed: 36117369
Wien Klin Wochenschr. 2022 Nov;134(21-22):772-778
pubmed: 36214904
Colorectal Dis. 2013 Dec;15(12):e749-56
pubmed: 24125518
Br J Surg. 1995 Feb;82(2):216-22
pubmed: 7749697
Digestion. 2022;103(4):253-260
pubmed: 35605592
Acta Obstet Gynecol Scand. 2023 Apr;102(4):473-479
pubmed: 36707852
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Am J Surg. 2002 Feb;183(2):110-6
pubmed: 11918872
Int J Colorectal Dis. 2012 Jun;27(6):781-7
pubmed: 22200793
Int J Colorectal Dis. 2020 Nov;35(11):2041-2048
pubmed: 32627072
Tech Coloproctol. 2013 Aug;17(4):431-6
pubmed: 23345041
World J Gastroenterol. 2014 Jun 14;20(22):7027-33
pubmed: 24944498
Colorectal Dis. 2013 Nov;15(11):e680-5
pubmed: 23890098
World J Clin Cases. 2020 Dec 6;8(23):5876-5886
pubmed: 33344586
Ann Gastroenterol Surg. 2020 Jul 18;4(5):597-601
pubmed: 33005855
Colorectal Dis. 2016 Mar;18(3):273-8
pubmed: 26391837
Gastroenterology. 2012 Nov;143(5):1179-1187.e3
pubmed: 22885331
Int J Colorectal Dis. 2004 Nov;19(6):554-60
pubmed: 15205989
J Laparoendosc Adv Surg Tech A. 2007 Aug;17(4):429-34
pubmed: 17705721
Surg Endosc. 2006 Jan;20(1):159-65
pubmed: 16333553
Colorectal Dis. 2013 Aug;15(8):1000-6
pubmed: 23527571
Clin Res Hepatol Gastroenterol. 2019 Nov;43(6):682-687
pubmed: 30880096
J Clin Med. 2021 Nov 08;10(21):
pubmed: 34768731
Gastroenterol Clin Biol. 2008 Mar;32(3):328-36
pubmed: 18403147
Surg Endosc. 2015 Mar;29(3):620-6
pubmed: 25030476
Front Med (Lausanne). 2021 Oct 20;8:746990
pubmed: 34746183
Value Health. 2009 Jan-Feb;12(1):181-4
pubmed: 19911447
Ann Surg. 2006 Feb;243(2):143-9; discussion 150-3
pubmed: 16432345
Rev Esp Enferm Dig. 2005 Nov;97(11):794-804
pubmed: 16438623
J Laparoendosc Adv Surg Tech A. 2022 Feb;32(2):125-131
pubmed: 33449870
Tech Coloproctol. 2009 Sep;13(3):215-7
pubmed: 19618253
Gastroenterol Clin Biol. 2004 Jan;28(1):16-20
pubmed: 15041805
J Psychosom Res. 2006 Oct;61(4):469-77
pubmed: 17011354
Chirurg. 2013 Jan;84(1):30-4, 36-8
pubmed: 23263683
JAMA Surg. 2021 Feb 1;156(2):129-136
pubmed: 33206182
Cureus. 2021 Aug 23;13(8):e17374
pubmed: 34584784
Gastroenterol Clin Biol. 1999 Jan;23(1):25-31
pubmed: 10219601